Discover
AUTL
Autolus Therapeutics plc
1.58
2 x 1.15
2 x 1.99
bid
ask
-
0.02
1.25%
2 @ 07:23 AM
1.56 -0.02 (1.52%)
| Ytd | -20.60% | |
| 1y | -31.00% |
1.55
day range
1.63
1.18
52 week range
2.70
| Open | 1.60 | Prev Close | 1.60 | Low | 1.55 | High | 1.63 | Mkt Cap | 420.51M |
| Vol | 685.06K | Avg Vol | 1.39M | EPS | -1.09 | P/E | N/A | Forward P/E | -3.08 |
| Beta | 2.04 | Short Ratio | 2.48 | Inst. Own | 77.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.59 | 200-d Avg | 1.54 | 1yr Est | 10.45 |
| Income Statement | |||
| Total Revenue | 26.22M | ||
| Revenues (USD) | 26.22M | ||
| Cost of Revenue | 24.57M | ||
| Gross Profit | 1.65M | ||
| Operating Expenses | 61.16M | ||
| Research and Development Expense | 21.21M | ||
| Selling, General and Administrative Expense | 39.95M | ||
| Operating Income | -59.51M | ||
| Interest Expense | 11.12M | ||
| Income Tax Expense | 863.00K | ||
| Net Income | -71.60M | ||
| Net Income Common Stock | -71.60M | ||
| Net Income Common Stock (USD) | -71.60M | ||
| Consolidated Income | -71.60M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -59.61M | ||
| Earning Before Interest & Taxes (USD) | -59.61M | ||
| Weighted Average Shares | 266.14M | ||
| Weighted Average Shares Diluted | 266.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 132.42M | ||
| Cash and Equivalents (USD) | 132.42M | ||
| Investments | 99.52M | ||
| Investments Current | 98.51M | ||
| Investments Non-Current | 1.01M | ||
| Trade and Non-Trade Receivables | 27.66M | ||
| Current Assets | 368.84M | ||
| Property, Plant & Equipment Net | 134.47M | ||
| Total Assets | 527.07M | ||
| Debt Current | 14.96M | ||
| Total Debt | 369.12M | ||
| Current Liabilities | 63.60M | ||
| Debt Non-Current | 354.16M | ||
| Total Liabilities | 418.24M | ||
| Accumulated Retained Earnings (Deficit) | -1.46B | ||
| Accumulated Other Comprehensive Income | -6.63M | ||
| Shareholders Equity | 108.83M | ||
| Shareholders Equity (USD) | 108.83M | ||
| Assets Non-Current | 158.23M | ||
| Total Debt (USD) | 369.12M | ||
| Goodwill and Intangible Assets | 18.98M | ||
| Inventory | 33.23M | ||
| Liabilities Non-Current | 354.64M | ||
| Trade and Non-Trade Payables | 2.35M | ||
| Tax Assets | 3.58M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.58M | ||
| Net Cash Flow from Financing | -2.06M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 26.78M | ||
| Capital Expenditure | -2.69M | ||
| Issuance (Repayment) of Debt Securities | -2.06M | ||
| Net Cash Flow from Investing | 96.15M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 98.84M | ||
| Net Cash Flow from Operations | -65.32M | ||
| Effect of Exchange Rate Changes on Cash | -1.99M | ||
| Share Based Compensation | 3.57M | ||